National Institutes of Health
Immune Tolerance Network (UM1 Clinical Trial Required)
Immune Tolerance Network (UM1 Clinical Trial Required) is a funding opportunity from National Institutes of Health, closing January 29, 2027.
Overview
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the continued support of the Collaborative Network for Clinical Research on Immune Tolerance. The purpose of this program is to enhance understanding of the underlying mechanisms of the induction, maintenance, and…